Search

everythinglearnresearchcommunity

for

Search:↓

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

ANXA1 influences hair growth in mice through the EGF signaling pathway.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

The composite sponge helps heal diabetic wounds by reducing inflammation and promoting new blood vessel growth.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The new treatment using microneedle patches shows promise for better hair growth in androgenetic alopecia.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Finasteride and dutasteride might lower melanoma risk.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Targeted nanomodulators can rejuvenate cells and promote hair growth in androgenetic alopecia.

MR antagonists may improve skin health and wound healing, especially in aging.

Ethanol embolization and debridement successfully treated a scalp AVM, stopped bleeding, and restored hair growth.

Blocking a protein called CXXC5 with a specific peptide can stimulate hair regrowth and new hair growth in wounds.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.